Titre : | Use of immediate release melatonin in psychiatry : BMI impacts the daily-dose (2021) |
Auteurs : | VEYRIER M ; ARIOUAT I ; JACOB A ; TROUT H ; BLOCH V ; DELAVEST M ; BELLIVIER F ; GEOFFROY PA |
Type de document : | Article |
Dans : | ENCEPHALE (2 vol 47, 2021) |
Article en page(s) : | 96-101 |
Descripteurs |
[SANTEPSY] CHRONOBIOLOGIE [SANTEPSY] EFFICACITE [SANTEPSY] INDICE DE MASSE CORPORELLE [SANTEPSY] MELATONINE [SANTEPSY] METABOLISME [SANTEPSY] OBSERVATION [SANTEPSY] TROUBLE DU SOMMEIL |
Résumé : | There is a growing interest in psychiatry regarding melatonin use both for its soporific and chronobiotic effects. This study aimed to evaluate factors impacting the daily-dose. n a university department of psychiatry in Paris (France), we conducted a posteriori naturalistic observational study from April 03, 2017 to January 31, 2018. We assessed links between sociodemographic and clinical characteristics and daily dose of melatonin (the daily-dose of melatonin initiation and the daily-dose at Hospital discharge). A survey of drug interactions was performed regarding metabolic inducers and inhibitors of the cytochrome P450 1A2 [Extrait du résumé d'auteur] |
En ligne : | https://www.em-premium.com/article/1434027 |